Questions about a product, technology or experimental design? Give us a call 610-644-8845. For special institutional pricing, check out our Distributors!
Questions about a product, technology or experimental design? Give us a call 610-644-8845.

LifeSensors Attends Bio Convention 2019 in Philadelphia

LIFESENSORS ATTENDS BIO CONVENTION 2019 IN PHILADELPHIA


The Bio International Convention will be in Philadelphia from June 3-6, 2019. More than 16,000 biotech and pharmaceutical leaders will attend and network to explore new opportunities and partnerships.

LifeSensors, a leading biotech company in Ubiquitin Proteasome System (UPS), drug discovery, diagnostics and research, will attend BIO 2019.

Please join LifeSensors at Booth 4132 in the Exhibit Hall.

We look forward to sharing the latest developments in UPS drug discovery, PROTAC drugs and ubiquitin proteomics with you.

 

Share this article:

Related Articles

With ubiquitin’s core functions in plants and animals being so similar it has long been speculated that insights into the

The functional consequences of protein polyubiquitination are determined by the type of ubiquitin chain assembled on the substrate. Among the

While direct K-RAS inhibitors represent a major therapeutic advance, targeting this oncoprotein remains a significant challenge due to limited druggable

Pan-selective Tandem Ubiquitin-Binding Entities (TUBEs) are engineered, high-affinity reagents composed of multiple ubiquitin-associated (UBA) domains that bind polyubiquitin chains with

LifeSensors is pleased to bring attention to some of our academic colleagues who have used our products in the past

Different lysines on ubiquitin are involved in forming different ubiquitin chains, with K48-linked chains primarily signaling for proteasomal degradation, while

With ubiquitin’s core functions in plants and animals being so similar it has long been speculated that insights into the

The functional consequences of protein polyubiquitination are determined by the type of ubiquitin chain assembled on the substrate. Among the

While direct K-RAS inhibitors represent a major therapeutic advance, targeting this oncoprotein remains a significant challenge due to limited druggable

Pan-selective Tandem Ubiquitin-Binding Entities (TUBEs) are engineered, high-affinity reagents composed of multiple ubiquitin-associated (UBA) domains that bind polyubiquitin chains with

LifeSensors is pleased to bring attention to some of our academic colleagues who have used our products in the past

Different lysines on ubiquitin are involved in forming different ubiquitin chains, with K48-linked chains primarily signaling for proteasomal degradation, while

Menu

Learning Center